STOCK TITAN

[SCHEDULE 13D/A] MEDIROM Healthcare Technologies Inc. American Depositary Share SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

MEDIROM Healthcare Technologies Inc. (MRM) amendment updates beneficial ownership and related disclosures for CEO Kouji Eguchi and COZY LLC. Mr. Eguchi is reported to beneficially own 2,075,003 Common Shares, representing 25.77% of the class using an adjusted share base; COZY LLC beneficially owns 47,543 Common Shares (0.60%). The filing attributes the percentage change to the issuer issuing additional ADSs on December 11, 2024 rather than purchases by the reporting persons. The filing discloses that Mr. Eguchi holds stock options exercisable for 150,000 shares within 60 days and an additional 36,500 options subject to revenue targets. The amendment notes the joint filing, acquisitions by COZY since the original Schedule 13D, a transfer of 7,500 shares by Mr. Eguchi in June 2025, and that this Amendment No. 1 was filed late.

MEDIROM Healthcare Technologies Inc. (MRM) — l'emendamento aggiorna le informazioni sulla titolarità beneficiaria e le relative comunicazioni per l'Amministratore Delegato Kouji Eguchi e per COZY LLC. Il sig. Eguchi detiene utilmente 2.075.003 azioni ordinarie, corrispondenti al 25,77% della classe calcolata su una base azionaria rettificata; COZY LLC possiede utilmente 47.543 azioni ordinarie (0,60%). La variazione percentuale è attribuita, secondo il deposito, all'emissione da parte dell'emittente di ADS aggiuntivi l'11 dicembre 2024 e non ad acquisti da parte dei soggetti segnalanti. Il deposito indica inoltre che il sig. Eguchi ha opzioni su azioni esercitabili per 150.000 titoli entro 60 giorni e ulteriori 36.500 opzioni subordinate al raggiungimento di obiettivi di fatturato. L'emendamento segnala la dichiarazione congiunta, gli acquisiti effettuati da COZY dopo il primo Schedule 13D, il trasferimento di 7.500 azioni da parte del sig. Eguchi nel giugno 2025 e che il presente Amendment No. 1 è stato presentato in ritardo.

MEDIROM Healthcare Technologies Inc. (MRM) — la enmienda actualiza la titularidad beneficiaria y las divulgaciones relacionadas para el CEO Kouji Eguchi y COZY LLC. El Sr. Eguchi posee beneficiariamente 2.075.003 acciones ordinarias, equivalentes al 25,77% de la clase sobre una base de acciones ajustada; COZY LLC posee beneficiariamente 47.543 acciones ordinarias (0,60%). El cambio porcentual se atribuye, según la presentación, a la emisión por parte del emisor de ADS adicionales el 11 de diciembre de 2024 y no a compras realizadas por las personas informantes. La presentación también revela que el Sr. Eguchi tiene opciones sobre acciones ejercitables por 150.000 títulos dentro de 60 días y otras 36.500 opciones condicionadas a objetivos de ingresos. La enmienda señala la presentación conjunta, adquisiciones realizadas por COZY desde el Schedule 13D original, una transferencia de 7.500 acciones por parte del Sr. Eguchi en junio de 2025 y que este Amendment No. 1 se presentó con retraso.

MEDIROM Healthcare Technologies Inc. (MRM) — 본 수정안은 최고경영자(CEO) Kouji Eguchi 및 COZY LLC의 실질 소유 및 관련 공시 내용을 갱신합니다. Eguchi 씨는 실제로 2,075,003 보통주를 보유하고 있으며, 조정된 주식 기준으로 해당 계급의 25.77%에 해당합니다. COZY LLC는 47,543 주의 보통주(0.60%)를 실질 보유하고 있습니다. 제출서에 따르면 비율 변화는 보고인들의 매수 때문이 아니라 발행사가 2024년 12월 11일에 추가 ADS를 발행한 데 기인합니다. 제출서에는 Eguchi 씨가 60일 내 행사 가능한 150,000주의 스톡옵션과 매출 목표 달성 조건의 추가 36,500주 옵션을 보유하고 있음도 공개되어 있습니다. 수정안은 공동 제출, 최초 Schedule 13D 이후 COZY의 취득, Eguchi 씨가 2025년 6월에 7,500주를 양도한 사실, 그리고 본 Amendment No. 1이 지연 제출되었음을 밝혀두고 있습니다.

MEDIROM Healthcare Technologies Inc. (MRM) — l'amendement met à jour la propriété bénéficiaire et les divulgations connexes concernant le PDG Kouji Eguchi et COZY LLC. M. Eguchi détient à titre bénéficiaire 2 075 003 actions ordinaires, soit 25,77% de la catégorie sur une base d'actions ajustée ; COZY LLC détient bénéficiairement 47 543 actions ordinaires (0,60%). La variation en pourcentage est attribuée, selon le dépôt, à l'émission par l'émetteur d'ADS supplémentaires le 11 décembre 2024 et non à des achats effectués par les personnes déclarantes. Le dépôt révèle également que M. Eguchi dispose d'options sur 150 000 actions exerçables dans les 60 jours et de 36 500 options supplémentaires soumises à des objectifs de chiffre d'affaires. L'amendement mentionne le dépôt conjoint, les acquisitions par COZY depuis le Schedule 13D initial, le transfert de 7 500 actions par M. Eguchi en juin 2025, et que cet Amendment No. 1 a été déposé en retard.

MEDIROM Healthcare Technologies Inc. (MRM) — die Änderung aktualisiert Angaben zur wirtschaftlichen Eigentümerschaft und zugehörige Offenlegungen für CEO Kouji Eguchi und COZY LLC. Herr Eguchi hält wirtschaftlich 2.075.003 Stammaktien, was auf einer bereinigten Aktienbasis 25,77% der Klasse entspricht; COZY LLC hält wirtschaftlich 47.543 Stammaktien (0,60%). Die prozentuale Änderung wird in der Einreichung darauf zurückgeführt, dass der Emittent am 11. Dezember 2024 zusätzliche ADS ausgegeben hat und nicht auf Käufe der meldenden Personen. Die Einreichung legt außerdem offen, dass Herr Eguchi Optionsrechte auf 150.000 Aktien ausübbar innerhalb von 60 Tagen sowie weitere 36.500 Optionen abhängig von Umsatzzielen hält. Die Änderung vermerkt die gemeinsame Einreichung, Erworbene von COZY seit dem ursprünglichen Schedule 13D, eine Übertragung von 7.500 Aktien durch Herrn Eguchi im Juni 2025 sowie dass dieses Amendment Nr. 1 verspätet eingereicht wurde.

Positive
  • Clear quantification of insider ownership: 2,075,003 shares (25.77%) for Mr. Eguchi and 47,543 shares (0.60%) for COZY
  • Addition of COZY LLC as a joint filer clarifies related-party holdings and control
  • Disclosure of option grants including 150,000 exercisable within 60 days and 36,500 performance-contingent options
Negative
  • Late filing of Amendment No. 1, reducing timeliness of investor disclosure
  • Potential dilution from 150,000 exercisable options and additional performance-based options
  • Limited recent trading transparency: reporting persons state no transactions in the past 60 days despite earlier acquisitions by COZY

Insights

TL;DR: Disclosure clarifies ownership concentration and option grants; late filing reduces disclosure timeliness.

The amendment provides clear quantification of Mr. Eguchi and COZY ownership: 2,075,003 shares (25.77%) and 47,543 shares (0.60%), respectively, and explains the change arose from the issuer issuing ADSs rather than new acquisitions by Mr. Eguchi. Material details include 150,000 options exercisable within 60 days and 36,500 performance-contingent options. From an investor disclosure perspective, the filing improves transparency on insider holdings and potential dilution. The late filing, however, reduces the contemporaneous usefulness of the disclosure and is relevant for governance and market-timing considerations.

TL;DR: Consolidates related-party holdings under joint filer status and documents insider option terms and a share transfer.

The amendment adds COZY LLC as a joint filer and states COZY is wholly owned by Mr. Eguchi, aligning beneficial ownership reporting. It documents a June 2025 transfer of 7,500 shares and details option series including exercise prices and performance conditions for the 11th Series. These disclosures are important for assessing control, potential dilution, and related-party arrangements. The late filing signals a compliance lapse but the content itself focuses on ownership reconciliation rather than strategic changes.

MEDIROM Healthcare Technologies Inc. (MRM) — l'emendamento aggiorna le informazioni sulla titolarità beneficiaria e le relative comunicazioni per l'Amministratore Delegato Kouji Eguchi e per COZY LLC. Il sig. Eguchi detiene utilmente 2.075.003 azioni ordinarie, corrispondenti al 25,77% della classe calcolata su una base azionaria rettificata; COZY LLC possiede utilmente 47.543 azioni ordinarie (0,60%). La variazione percentuale è attribuita, secondo il deposito, all'emissione da parte dell'emittente di ADS aggiuntivi l'11 dicembre 2024 e non ad acquisti da parte dei soggetti segnalanti. Il deposito indica inoltre che il sig. Eguchi ha opzioni su azioni esercitabili per 150.000 titoli entro 60 giorni e ulteriori 36.500 opzioni subordinate al raggiungimento di obiettivi di fatturato. L'emendamento segnala la dichiarazione congiunta, gli acquisiti effettuati da COZY dopo il primo Schedule 13D, il trasferimento di 7.500 azioni da parte del sig. Eguchi nel giugno 2025 e che il presente Amendment No. 1 è stato presentato in ritardo.

MEDIROM Healthcare Technologies Inc. (MRM) — la enmienda actualiza la titularidad beneficiaria y las divulgaciones relacionadas para el CEO Kouji Eguchi y COZY LLC. El Sr. Eguchi posee beneficiariamente 2.075.003 acciones ordinarias, equivalentes al 25,77% de la clase sobre una base de acciones ajustada; COZY LLC posee beneficiariamente 47.543 acciones ordinarias (0,60%). El cambio porcentual se atribuye, según la presentación, a la emisión por parte del emisor de ADS adicionales el 11 de diciembre de 2024 y no a compras realizadas por las personas informantes. La presentación también revela que el Sr. Eguchi tiene opciones sobre acciones ejercitables por 150.000 títulos dentro de 60 días y otras 36.500 opciones condicionadas a objetivos de ingresos. La enmienda señala la presentación conjunta, adquisiciones realizadas por COZY desde el Schedule 13D original, una transferencia de 7.500 acciones por parte del Sr. Eguchi en junio de 2025 y que este Amendment No. 1 se presentó con retraso.

MEDIROM Healthcare Technologies Inc. (MRM) — 본 수정안은 최고경영자(CEO) Kouji Eguchi 및 COZY LLC의 실질 소유 및 관련 공시 내용을 갱신합니다. Eguchi 씨는 실제로 2,075,003 보통주를 보유하고 있으며, 조정된 주식 기준으로 해당 계급의 25.77%에 해당합니다. COZY LLC는 47,543 주의 보통주(0.60%)를 실질 보유하고 있습니다. 제출서에 따르면 비율 변화는 보고인들의 매수 때문이 아니라 발행사가 2024년 12월 11일에 추가 ADS를 발행한 데 기인합니다. 제출서에는 Eguchi 씨가 60일 내 행사 가능한 150,000주의 스톡옵션과 매출 목표 달성 조건의 추가 36,500주 옵션을 보유하고 있음도 공개되어 있습니다. 수정안은 공동 제출, 최초 Schedule 13D 이후 COZY의 취득, Eguchi 씨가 2025년 6월에 7,500주를 양도한 사실, 그리고 본 Amendment No. 1이 지연 제출되었음을 밝혀두고 있습니다.

MEDIROM Healthcare Technologies Inc. (MRM) — l'amendement met à jour la propriété bénéficiaire et les divulgations connexes concernant le PDG Kouji Eguchi et COZY LLC. M. Eguchi détient à titre bénéficiaire 2 075 003 actions ordinaires, soit 25,77% de la catégorie sur une base d'actions ajustée ; COZY LLC détient bénéficiairement 47 543 actions ordinaires (0,60%). La variation en pourcentage est attribuée, selon le dépôt, à l'émission par l'émetteur d'ADS supplémentaires le 11 décembre 2024 et non à des achats effectués par les personnes déclarantes. Le dépôt révèle également que M. Eguchi dispose d'options sur 150 000 actions exerçables dans les 60 jours et de 36 500 options supplémentaires soumises à des objectifs de chiffre d'affaires. L'amendement mentionne le dépôt conjoint, les acquisitions par COZY depuis le Schedule 13D initial, le transfert de 7 500 actions par M. Eguchi en juin 2025, et que cet Amendment No. 1 a été déposé en retard.

MEDIROM Healthcare Technologies Inc. (MRM) — die Änderung aktualisiert Angaben zur wirtschaftlichen Eigentümerschaft und zugehörige Offenlegungen für CEO Kouji Eguchi und COZY LLC. Herr Eguchi hält wirtschaftlich 2.075.003 Stammaktien, was auf einer bereinigten Aktienbasis 25,77% der Klasse entspricht; COZY LLC hält wirtschaftlich 47.543 Stammaktien (0,60%). Die prozentuale Änderung wird in der Einreichung darauf zurückgeführt, dass der Emittent am 11. Dezember 2024 zusätzliche ADS ausgegeben hat und nicht auf Käufe der meldenden Personen. Die Einreichung legt außerdem offen, dass Herr Eguchi Optionsrechte auf 150.000 Aktien ausübbar innerhalb von 60 Tagen sowie weitere 36.500 Optionen abhängig von Umsatzzielen hält. Die Änderung vermerkt die gemeinsame Einreichung, Erworbene von COZY seit dem ursprünglichen Schedule 13D, eine Übertragung von 7.500 Aktien durch Herrn Eguchi im Juni 2025 sowie dass dieses Amendment Nr. 1 verspätet eingereicht wurde.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
With respect to rows 7, 9, and 11 immediately above, the aggregate amount of shares beneficially owned by Kouji Eguchi reflects (i) 1,877,460 Common Shares, no par value per share (the "Common Shares"), of the Issuer held by Mr. Eguchi, (ii) 22,543 American Depositary Shares of the Issuer, each representing one Common Share (the "ADSs"), held by COZY LLC, a limited liability company (godo kaisha) organized under the laws of Japan that is wholly owned and controlled by Mr. Eguchi ("COZY"), (iii) an aggregate of 150,000 Common Shares that may be issued upon exercise of stock options held by Mr. Eguchi that are exercisable within 60 days from the date hereof, and (iv) 25,000 Common Shares held by COZY. With respect to row 13 immediately above, the percentage is based on (i) 7,901,950 Common Shares issued and outstanding as of December 31, 2024, as reported in the Issuer's annual report on form 20-F for the year ended December 31, 2024, filed by the Issuer with the U.S. Securities and Exchange Commission on April 29, 2025, and (ii) 150,000 Common Shares that may be issued upon exercise of stock options held by Mr. Eguchi that are exercisable within 60 days from the date hereof, which are deemed to be outstanding for the purpose of computing the percentage of outstanding securities owned by Mr. Eguchi.


SCHEDULE 13D




Comment for Type of Reporting Person:
With respect to rows 7, 9, and 11 immediately above, the aggregate amount of shares beneficially owned by COZY reflects (i) 22,543 ADSs of the Issuer held by COZY and (ii) 25,000 Common Shares held by COZY. With respect to row 13 immediately above, the percentage is based on 7,901,950 Common Shares issued and outstanding as of December 31, 2024, as reported in the Issuer's annual report on form 20-F for the year ended December 31, 2024, filed by the Issuer with the U.S. Securities and Exchange Commission on April 29, 2025.


SCHEDULE 13D


Kouji Eguchi
Signature:/s/ Kouji Eguchi
Name/Title:Kouji Eguchi
Date:09/02/2025
COZY LLC
Signature:/s/ Kouji Eguchi
Name/Title:Kouji Eguchi, Managing Member
Date:09/02/2025

FAQ

What stake does Kouji Eguchi report in MEDIROM (MRM)?

The filing states Mr. Eguchi beneficially owns 2,075,003 Common Shares, representing 25.77% of the class based on the assumptions in the amendment.

How many shares does COZY LLC hold in MRM?

COZY LLC is reported to beneficially own 47,543 Common Shares, representing 0.60% of the outstanding Common Shares.

Are there stock options disclosed in the Schedule 13D/A for MRM?

Yes. The amendment discloses 150,000 options exercisable within 60 days and an additional 36,500 options granted in July 2025 subject to revenue-based vesting.

Does the filing explain why the ownership percentage changed?

Yes. The amendment attributes the updated percentage to the issuer issuing additional ADSs on December 11, 2024, not to new acquisitions by Mr. Eguchi.

Was this Schedule 13D/A filed on time?

No. The amendment states it was filed late due to administrative oversight.
Medirom Healthcare Technologies Inc

NASDAQ:MRM

MRM Rankings

MRM Latest News

MRM Latest SEC Filings

MRM Stock Data

11.38M
5.81M
26.42%
2.69%
0.05%
Personal Services
Consumer Cyclical
Link
Japan
Tokyo